|
|||||
|
|
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK |
|
| Authors: | Claire N. Harrison Adam J. Mead Mark W. Drummond Gavin Chiu Rozinder Bains |
| Affiliation: | 1. Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, UK;2. MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK;3. Beatson Cancer Centre, University of Glasgow, Glasgow, UK;4. Novartis Pharmaceutical UK Ltd, Camberley, UK |
| Abstract: | |
| Keywords: | myelofibrosis diagnostic haematology therapy |